Myeloma survivor, fellow blogger and co-host of the monthly Myeloma Cure Panel broadcasts, Gary Petersen, followed up my on-air support group meeting Monday night, interviewing my guest, 14 year survivor Paula Van Ripper.
Paula’s story caught my attention for several reasons. She has been able to continue to work full-time for Rutgers University. Paula was also part of an important pomalidomide (Pomalyst/POM for short) study, and she is now also using the other “new kid on the block,” carfilzomib (Kyprolis), in combination with POM.
Tomorrow I’m going to continue my ongoing look inside the MMRF, focusing on the group’s new patient centered initiative, the MMRF Community Gateway.
Feel good and keep smiling! Pat